COMMITMENTS AND CONTINGENCIES - Narrative (Details)	9 Months Ended
	Sep. 30, 2023 USD ($) liability	Jan. 20, 2021 USD ($)	Jul. 29, 2019 USD ($)
Arkis
Loss Contingencies [Line Items]
Contingent consideration, estimated fair value			$ 25,500,000
Contingent consideration			13,100,000
Arkis | Development Milestones
Loss Contingencies [Line Items]
Contingent consideration, estimated fair value			10,000,000.0
Arkis | Commercial Sales Milestones
Loss Contingencies [Line Items]
Contingent consideration, estimated fair value			$ 15,500,000
Derma Sciences
Loss Contingencies [Line Items]
Number of contingent liabilities remaining | liability	1
Contingent consideration, maximum undiscounted payment amount	$ 3,000,000
Derma Sciences | BioD Earnout Payments and Medihoney Earnout Payments
Loss Contingencies [Line Items]
Payment for contingent consideration	$ 33,300,000
ACell, Inc.
Loss Contingencies [Line Items]
Contingent consideration		$ 23,900,000
ACell, Inc. | Revenue-Based Performance Milestones In 2023
Loss Contingencies [Line Items]
Contingent consideration, maximum undiscounted payment amount		50,000,000
ACell, Inc. | Revenue Based Performance Milestones In 2025
Loss Contingencies [Line Items]
Contingent consideration, maximum undiscounted payment amount		$ 50,000,000